| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-30 |
Sentence |
denotes |
[Juvenile pemphigus vulgaris]. |
| T1 |
0-30 |
Sentence |
denotes |
[Juvenile pemphigus vulgaris]. |
| TextSentencer_T2 |
31-62 |
Sentence |
denotes |
Pemphigus vulgaire de l'enfant. |
| T2 |
31-62 |
Sentence |
denotes |
Pemphigus vulgaire de l'enfant. |
| TextSentencer_T3 |
63-74 |
Sentence |
denotes |
BACKGROUND: |
| T3 |
63-74 |
Sentence |
denotes |
BACKGROUND: |
| TextSentencer_T4 |
75-165 |
Sentence |
denotes |
Pemphigus vulgaris is a rare autoimmune blistering disease seen only, rarely, in children. |
| T4 |
75-165 |
Sentence |
denotes |
Pemphigus vulgaris is a rare autoimmune blistering disease seen only, rarely, in children. |
| TextSentencer_T5 |
166-178 |
Sentence |
denotes |
CASE-REPORT: |
| T5 |
166-178 |
Sentence |
denotes |
CASE-REPORT: |
| TextSentencer_T6 |
179-288 |
Sentence |
denotes |
Two young girls, aged four and 15 years respectively, presented with oral and/or cutaneous blisters (case 2). |
| T6 |
179-288 |
Sentence |
denotes |
Two young girls, aged four and 15 years respectively, presented with oral and/or cutaneous blisters (case 2). |
| TextSentencer_T7 |
289-520 |
Sentence |
denotes |
The diagnosis of pemphigus vulgaris was confirmed by histology (suprabasal acantholysis) and immunopathological analysis (direct and indirect immunofluorescence, antidesmoglein-3 plus or minus antidesmoglein-1 antibodies by ELISA). |
| T7 |
289-520 |
Sentence |
denotes |
The diagnosis of pemphigus vulgaris was confirmed by histology (suprabasal acantholysis) and immunopathological analysis (direct and indirect immunofluorescence, antidesmoglein-3 plus or minus antidesmoglein-1 antibodies by ELISA). |
| TextSentencer_T8 |
521-673 |
Sentence |
denotes |
In case 2, caused by corticosteroid dependence and after the failure of intravenous immunoglobulin, the patient was successfully treated with rituximab. |
| T8 |
521-673 |
Sentence |
denotes |
In case 2, caused by corticosteroid dependence and after the failure of intravenous immunoglobulin, the patient was successfully treated with rituximab. |
| TextSentencer_T9 |
674-685 |
Sentence |
denotes |
DISCUSSION: |
| T9 |
674-685 |
Sentence |
denotes |
DISCUSSION: |
| TextSentencer_T10 |
686-823 |
Sentence |
denotes |
Juvenile pemphigus vulgaris is rare and its occasionally clinically atypical presentation can result in delayed diagnosis and management. |
| T10 |
686-823 |
Sentence |
denotes |
Juvenile pemphigus vulgaris is rare and its occasionally clinically atypical presentation can result in delayed diagnosis and management. |
| TextSentencer_T11 |
824-887 |
Sentence |
denotes |
Firstline therapy generally comprises systemic corticosteroids. |
| T11 |
824-887 |
Sentence |
denotes |
Firstline therapy generally comprises systemic corticosteroids. |
| TextSentencer_T12 |
888-1077 |
Sentence |
denotes |
Some cases of recalcitrant pemphigus vulgaris in adults with a refractory course, despite adequate systemic corticosteroids, have been successfully treated with rituximab, as in our case 2. |
| T12 |
888-1077 |
Sentence |
denotes |
Some cases of recalcitrant pemphigus vulgaris in adults with a refractory course, despite adequate systemic corticosteroids, have been successfully treated with rituximab, as in our case 2. |
| TextSentencer_T13 |
1078-1190 |
Sentence |
denotes |
To our knowledge, only two other cases of juvenile pemphigus vulgaris treated with rituximab have been reported. |
| T13 |
1078-1190 |
Sentence |
denotes |
To our knowledge, only two other cases of juvenile pemphigus vulgaris treated with rituximab have been reported. |